Compare MPAA & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPAA | BNR |
|---|---|---|
| Founded | 1968 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.8M | 233.7M |
| IPO Year | 1994 | 2020 |
| Metric | MPAA | BNR |
|---|---|---|
| Price | $12.69 | $16.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 164.8K | 68.7K |
| Earning Date | 11-10-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $789,115,000.00 | $75,749,382.00 |
| Revenue This Year | $10.44 | $136.32 |
| Revenue Next Year | $4.88 | N/A |
| P/E Ratio | $113.51 | ★ N/A |
| Revenue Growth | ★ 6.72 | 5.56 |
| 52 Week Low | $5.38 | $2.18 |
| 52 Week High | $18.12 | $23.59 |
| Indicator | MPAA | BNR |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 48.32 |
| Support Level | $12.65 | $15.71 |
| Resistance Level | $14.22 | $18.42 |
| Average True Range (ATR) | 0.63 | 2.38 |
| MACD | 0.12 | -0.71 |
| Stochastic Oscillator | 11.56 | 2.26 |
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.